$0.00
0.00%
Nasdaq, Fri, Jul 18 2025
ISIN
US00430H1023
Symbol
AXDX
Sector
Industry

Accelerate Diagnostics, Inc. Stock price

$0.00
-0.01 53.00% 1M
-1.07 99.56% 6M
-1.20 99.61% YTD
-1.13 99.58% 1Y
-13.50 99.97% 3Y
-172.10 100.00% 5Y
-286.80 100.00% 10Y
-3.10 99.85% 20Y
Nasdaq, Closing price Fri, Jul 18 2025
+0.00 0.00%
ISIN
US00430H1023
Symbol
AXDX
Sector
Industry

Key metrics

Basic
Market capitalization
$260.0k
Enterprise Value
$47.4m
Net debt
$47.2m
Cash
$16.3m
Shares outstanding
25.2m
Valuation (TTM | estimate)
P/E
negative | 0.0
P/S
0.0 | 0.0
EV/Sales
4.1 | 3.8
EV/FCF
negative
P/B
0.0
Financial Health
Equity Ratio
-196.3%
Return on Equity
89.3%
ROCE
1,337.6%
ROIC
-2,890.6%
Debt/Equity
-1.1
Financials (TTM | estimate)
Revenue
$11.7m | $12.6m
EBITDA
$-31.9m | $-40.4m
EBIT
$-35.3m | $-30.2m
Net Income
$-50.1m | $-51.4m
Free Cash Flow
$-24.7m
Growth (TTM | estimate)
Revenue
-3.0% | 7.3%
EBITDA
35.7% | -26.7%
EBIT
33.2% | 14.4%
Net Income
18.8% | -2.7%
Free Cash Flow
40.1%
Margin (TTM | estimate)
Gross
23.1%
EBITDA
-272.6% | -321.7%
EBIT
-301.9%
Net
-427.8% | -409.3%
Free Cash Flow
-211.2%
More
EPS
$-2.0
FCF per Share
$-1.0
Short interest
1.9%
Employees
107
Rev per Employee
$110.0k
Show more

Is Accelerate Diagnostics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

Accelerate Diagnostics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Accelerate Diagnostics, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Accelerate Diagnostics, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Accelerate Diagnostics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
12 12
3% 3%
100%
- Direct Costs 8.99 8.99
8% 8%
77%
2.70 2.70
28% 28%
23%
- Selling and Administrative Expenses 21 21
32% 32%
182%
- Research and Development Expense 17 17
34% 34%
143%
-32 -32
36% 36%
-273%
- Depreciation and Amortization 3.42 3.42
5% 5%
29%
EBIT (Operating Income) EBIT -35 -35
33% 33%
-302%
Net Profit -50 -50
19% 19%
-428%

In millions USD.

Don't miss a Thing! We will send you all news about Accelerate Diagnostics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Accelerate Diagnostics, Inc. Stock News

Neutral
PRNewsWire
2 months ago
TUCSON, Ariz. , May 8, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) ("Accelerate" or the Company") today announced that it has voluntarily initiated a Chapter 11 restructuring proceeding in the United States Bankruptcy Court for the District of Delaware ("Bankruptcy Court") and will seek to sell its assets through a court supervised sale process.
Neutral
PRNewsWire
4 months ago
TUCSON, Ariz. , March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate WAVE™ system and positive blood culture gram-negative test kit to the U.S. Food and Drug Administration (FDA) for 510(k) clearance.
Neutral
PRNewsWire
4 months ago
TUCSON, Ariz. , March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today reports financial results for the fourth quarter and year ended December 31, 2024.

Company Profile

Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.

Head office United States
CEO Jack Phillips
Employees 107
Founded 1982
Website acceleratediagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today